Elimination of Odor and Treatment of Malodorous Recalcitrant Wounds by Using Supraz and PRP-FG Versus Standard of Care

Launched by MASHHAD UNIVERSITY OF MEDICAL SCIENCES · Aug 1, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a new way to treat chronic wounds that have a strong odor and are difficult to heal. Researchers want to see if using a special gel called Supraz, along with a treatment derived from the patient's own blood (called platelet-rich plasma-fibrin glue), can help eliminate the bad smell and improve healing compared to standard wound care methods.

To participate in this study, you should have a single wound on your body that has not healed for at least three months and has not responded to regular cleaning and dressing changes. You also need to have a body mass index (BMI) between 18 and 35. Unfortunately, if you have certain health issues like cancer or heart failure, or if you are taking specific medications that could affect healing, you may not be eligible. If you join the trial, you will receive the new treatment and be monitored closely to see how well it works in improving your wound's condition. This is an exciting opportunity to contribute to research that could help others with similar challenges!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Having a single wound on the body that has been at least 3 months old and has not been repaired by wound irrigation with normal saline and changing the dressing
• • Having a body mass index of 18-35
• • Sign the informed consent by the patient
• Exclusion Criteria:
• • Having concurrent diseases that may cause problems in wound healing, such as cancers, vasculitis, kidney and liver failure, and heart failure
• • Taking certain drugs that may interfere with wound healing, such as corticosteroids, immunosuppressive agents, and cytotoxic agents